SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3dse'
List of Similar Pattern of Amino Acids| DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1J36_A_LPRA801_1 (ANGIOTENSINCONVERTING ENZYME) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 6 / 12 | THR A 220HIS A 223GLU A 224HIS A 227GLU A 262TYR A 366 | None ZN A 501 (-3.2A) ZN A 501 ( 4.4A) ZN A 501 (-3.3A) ZN A 501 (-1.9A)None | 0.95A | 1j36A-3dseA:undetectable | 1j36A-3dseA:20.73 | |||
| 1J36_B_LPRB802_1 (ANGIOTENSINCONVERTING ENZYME) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 6 / 12 | THR A 220HIS A 223GLU A 224HIS A 227GLU A 262TYR A 366 | None ZN A 501 (-3.2A) ZN A 501 ( 4.4A) ZN A 501 (-3.3A) ZN A 501 (-1.9A)None | 0.95A | 1j36B-3dseA:undetectable | 1j36B-3dseA:20.73 | |||
| 1J96_A_TESA903_1 (3ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE3) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 4 / 6 | TYR A 77VAL A 379ILE A 378LEU A 416 | None | 1.08A | 1j96A-3dseA:undetectable | 1j96A-3dseA:21.78 | |||
| 1UTD_Q_TRPQ81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 5 / 10 | GLY A 229HIS A 230HIS A 227ILE A 111THR A 265 | NoneNone ZN A 501 (-3.3A)NoneNone | 1.17A | 1utdQ-3dseA:undetectable1utdR-3dseA:undetectable | 1utdQ-3dseA:10.711utdR-3dseA:10.71 | |||
| 2OCU_A_TYLA3001_1 (LACTOTRANSFERRIN) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | LEU A 345TYR A 233GLY A 181 | None | 0.53A | 2ocuA-3dseA:undetectable | 2ocuA-3dseA:19.45 | |||
| 3KEC_B_HAEB271_1 (COLLAGENASE 3) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | HIS A 223GLU A 224HIS A 227 | ZN A 501 (-3.2A) ZN A 501 ( 4.4A) ZN A 501 (-3.3A) | 0.16A | 3kecB-3dseA:undetectable | 3kecB-3dseA:19.57 | |||
| 3U52_A_CUA515_0 (PHENOL HYDROXYLASECOMPONENT PHLPHENOL HYDROXYLASECOMPONENT PHN) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | HIS A 227HIS A 230ILE A 226 | ZN A 501 (-3.3A)NoneNone | 0.85A | 3u52A-3dseA:undetectable3u52C-3dseA:undetectable | 3u52A-3dseA:21.733u52C-3dseA:20.56 | |||
| 4PD9_A_ADNA501_2 (NUPC FAMILY PROTEIN) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | THR A 101ASN A 391PHE A 390 | None | 0.50A | 4pd9A-3dseA:undetectable | 4pd9A-3dseA:21.67 | |||
| 4PD9_A_ADNA501_2 (NUPC FAMILY PROTEIN) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | THR A 265ASN A 368PHE A 196 | None | 0.72A | 4pd9A-3dseA:undetectable | 4pd9A-3dseA:21.67 | |||
| 4R7L_A_SHHA709_1 (LEUKOTRIENE A-4HYDROLASE) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 5 / 12 | HIS A 223GLU A 224HIS A 227GLU A 262TYR A 366 | ZN A 501 (-3.2A) ZN A 501 ( 4.4A) ZN A 501 (-3.3A) ZN A 501 (-1.9A)None | 0.54A | 4r7lA-3dseA:3.7 | 4r7lA-3dseA:21.59 | |||
| 4W9N_C_CCSC1548_0 (ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 3 / 3 | ALA A 35TRP A 43VAL A 44 | None | 0.22A | 4w9nC-3dseA:undetectable | 4w9nC-3dseA:22.15 | |||
| 4YJI_A_TYLA502_1 (ARYL ACYLAMIDASE) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 4 / 7 | LEU A 345GLY A 234GLY A 179ILE A 293 | None | 0.70A | 4yjiA-3dseA:undetectable | 4yjiA-3dseA:22.16 | |||
| 5PAH_A_LDPA600_1 (PHENYLALANINE4-MONOOXYGENASE) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 4 / 4 | HIS A 227HIS A 223TYR A 366GLU A 262 | ZN A 501 (-3.3A) ZN A 501 (-3.2A)None ZN A 501 (-1.9A) | 1.18A | 5pahA-3dseA:undetectable | 5pahA-3dseA:21.15 | |||
| 6G2P_A_TRPA502_0 (FLAVIN-DEPENDENTL-TRYPTOPHAN OXIDASEVIOA) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 4 / 7 | ARG A 264TYR A 286LEU A 284TYR A 342 | None | 1.39A | 6g2pA-3dseA:undetectable | 6g2pA-3dseA:21.46 | |||
| 6JI6_A_ACTA305_0 (GLUTATHIONES-TRANSFERASECLASS-MU 26 KDAISOZYME) |
3dse | BOTULINUM NEUROTOXINTYPE A (Clostridiumbotulinum) | 4 / 5 | GLY A 181LEU A 175SER A 167GLN A 184 | None | 1.03A | 6ji6A-3dseA:undetectable | 6ji6A-3dseA:19.19 |